SCHEMBL17265

SCHEMBL17265

CCCN(C[C@@H]1CN(S(=O)(=O)c2cccs2)CCN1c1ccc(C(C)(O)C(F)(F)F)cc1)S(=O)(=O)c1cccnc1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.60
GCKR Q14397 8/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17980 0.91 GCK (0.62) GCKGCKR
SCHEMBL19447 0.90 GCK (0.63) GCKGCKR
SCHEMBL12078937 0.90 GCK (0.63) GCKGCKR
SCHEMBL16242 0.90 GCK (0.63) GCKGCKR
SCHEMBL16566 0.89 GCK (0.62) GCKGCKR
SCHEMBL17643 0.89 GCK (0.62) GCKGCKR
SCHEMBL12078799 0.89 GCK (0.62) GCKGCKR
SCHEMBL18093 0.88 GCK (0.60) GCKGCKR
SCHEMBL20013 0.88 GCK (0.60) GCKGCKR
SCHEMBL18119 0.88 GCK (0.60) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed